One of the largest pharmaceutical companies in the world
Travel and entertainment expenditures for one of the world’s largest pharmaceutical companies had exceeded $700 million globally. With that volume of T&E transactions, millions of HCP records, and a project already underway to upgrade the expense application, the mission was to improve expense reporting processes for the US Sunshine Act requirements, design a new solution to meet the France Sunshine Act requirements, and manage the complex priorities of stakeholders, project teams, and vendors.
Approach: Think + Do
To define and prioritize requirements, we consolidated and reviewed US requirements, current pain points, and France’s requirements for the Sunshine Act. We then created a set of design options for the new process and system. After performing analysis to reach an agreement on the best solution for compliance, operations, and users, the transparency strategy and design was complete. From there we set about implementing the solution, managing cross-functional teams from multiple organizations and locations, and managing the change to affected business units and end users.
We successfully provided an updated Sunshine Act compliant T&E solution to two countries with 50,000 employees. The client met all key milestones for the readiness of legal requirements, experiencing no operational problems during the cutover process, which was successfully completed on time and on budget. The overall success of the project led to an invitation for Acquis to participate in the on-going global transparency meetings.